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Abstract 
Background: The endocannabinoid system is involved in the regulation of stress and anxiety. In a recent study, it was 
reported that short‑term changes in mood produced by a pleasant ambience were correlated with changes in the 
levels of plasma endocannabinoids and related N‑acylethanolamines (Schrieks et al. PLoS One 10: e0126421, 2015). 
In the present study, we investigated whether stress reduction by touch massage (TM) affects blood plasma levels of 
endocannabinoids and related N‑acylethanolamines.
Results: A randomized two‑session crossover design for 20 healthy participants was utilised, with one condition that 
consisted of TM and a rest condition as control. TM increased the perceived pleasantness rating of the participants, 
and both TM and rest reduced the basal anxiety level as assessed by the State scale of the STAI‑Y inventory. However, 
there were no significant effects of either time (pre‑ vs. post‑treatment measures) as main effect or the interaction 
time x treatment for the plasma levels of the endocannabinoids anandamide and 2‑arachidonoylglycerol or for eight 
other related lipids. Four lipids showed acceptable relative reliabilities, and for two of these (linoleoyl ethanolamide 
and palmitoleoyl ethanolamide) a significant correlation was seen between the TM‑related change in levels, calcu‑
lated as (post‑TM value minus pre‑TM value) − (post‑rest value minus pre‑rest value), and the corresponding TM‑
related change in perceived pleasantness.
Conclusions: It is concluded that in the participants studied here, there are no overt effects of TM upon plasma 
endocannabinoid levels. Possible associations of related N‑acylethanolamines with the perceived pleasantness should 
be investigated further.
Keywords: Endocannabinoid, Palmitoylethanolamide, Oleoylethanolamide, Linoleoyl ethanolamide, Touch massage, 
Anxiety, Stress, Blood plasma, Perceived pleasantness
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Background
For centuries, extracts of the Cannabis sativa plant have 
been used for their therapeutic and recreational proper-
ties. ∆9-Tetrahydrocannabinol, the main psychoactive 
ingredient of cannabis produces its effects via activa-
tion of two cannabinoid (CB) receptors, CB1 and CB2. 
CB1 receptors are the most abundant G protein-coupled 
receptor expressed in the brain but are also found in 
cells and tissues outside the central nervous system. CB2 
receptors are mainly expressed in cells of the immune tis-
sue but have also been identified in the CNS [1, 2]. The 
most well-characterised endogenous CB receptor ligands 
(endocannabinoids, eCBs) are the arachidonic acid deriv-
atives anandamide (AEA) [3] and 2-arachidonglycerol 
(2-AG) [4, 5]. AEA belongs to the N-acylethanolamine 
(NAE) class of lipids, which includes other putative eCB 
ligands such as docosatetraenoyl ethanolamide (DEA) [6] 
as well as the anti-inflammatory compounds palmitoyle-
thanolamide (PEA) and stearoylethanolamide (SEA) [7, 
8], the satiety factor oleoylethanolamide (OEA) [9] and 
other less well-characterised compounds such as lino-
leoyl ethanolamide (LEA), palmitoleoyl ethanolamide 
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(POEA) and eicosapentaenoyl ethanolamide (EPEA). 
NAEs are catabolised by hydrolysis to the corresponding 
long-chain fatty acids, but AEA can also be metabolised 
to other compounds including N-arachidonoylglycine 
(NA-Gly) [10], which has biological properties of its own 
[11].
The endocannabinoid (eCB) system is involved in a 
wide variety of effects in the body, including the inhibi-
tion of central transmitter release and the regulation of 
appetite and pain perception [12]. A substantial amount 
of research has linked the eCB system to stress, fear and 
anxiety. One hypothesised function for the eCB system 
is to buffer or dampen the endocrine and behavioural 
effects of acute stress and negative stimuli [13, 14] and 
in humans increased levels of eCB have been detected in 
serum after exposure to acute stress [15]. Both decreases 
[16] and increases [17] in plasma eCB levels have been 
reported for individuals with post-traumatic stress disor-
der. Loss of eCB tone can result in mood disturbances in 
man: the CB1 receptor antagonist/inverse agonist rimon-
abant was briefly marketed for weight reduction. The 
medication was effective, patients lost weight and expe-
rienced food less pleasurably. However, after a short time 
on the market, the drug was withdrawn due an unfavour-
able risk of developing depressive disorders, mood altera-
tions with depressive symptoms, and anxiety [18].
In a recent study [19], it was reported that in healthy 
women, the eCB system was responsive to mood changes 
produced by the ambient environment. These authors 
utilised a randomised cross-over study whereby the 
plasma levels of AEA, 2-AG, PEA and SEA were meas-
ured during the partaking of a meal under conditions 
of either pleasant or unpleasant ambience. The authors 
found that levels of SEA and PEA were changed during 
the experience, and that the lipids were correlated with 
measures of mood [19]. This raises the question as to 
whether other acute mood-changing interventions can 
affect these lipids in a similar manner. Human touch is 
involved in many rewarding behaviours and is consid-
ered to be an inherited, gene specified reward [20]. Touch 
massage (TM) and human touch reduce stress and anxi-
ety and increase well-being and relaxation in humans 
[21–24]. In the present randomised cross-over study, we 
have investigated whether touch massage also affects the 
plasma levels of eCBs and related lipids.
Results
Influence of the interventions upon behavioural 
and stress‑related measures
Twenty healthy individuals participated in the study. 
The individuals were randomly divided into two groups, 
one group (N =  10) experiencing a rest phase (60  min) 
between blood sampling on the first occasion and 60 min 
of TM between blood sampling on the second occasion. 
The other group (N  =  10) was treated in the reverse 
order to give a maximum of 20 cases in this randomised 
cross-over study (for schematic, showing the sampling 
times, see Fig. 1). The values for all rest and TM condi-
tions were then collated. The initial stress levels (i.e. prior 
to blood sampling) on a 5 point scale (5 worst) were not 
significantly different between the rest conditions and 
the TM conditions, median (range) scores of 1.5 (0–5) 
and 2 (0–3.5) being found for rest and TM, respectively 
(P  =  0.61, Wilcoxon’s matched pairs signed rank test). 
Similarly, pre-treatment saliva cortisol levels (nmol) were 
not different, median (range) scores of 8.8 (4.4–17.2) and 
8.7 (3.4–18.6) being found for rest and TM, respectively 
(P = 0.77, Wilcoxon’s matched pairs signed rank test).
The effects of TM upon perceived pleasantness, the 
heart rate, the total scores in the state and trait arms 
of the State-Trait Anxiety Inventory Form Y (STAI-
Y) and the Montgomery-Åsberg Depression Rating 
scale (MADRS) are shown in Fig. 2. Each panel shows 
the individual data points plotted with the x-axis rep-
resenting the pre-treatment value, and the y-axis rep-
resenting the post-treatment value. The correlations 
between the pre- and post-treatment values were very 
high for all variables (Additional file  1). However, the 
primary aim of the plots is to provide a simple visual 
representation of the individual data. In this respect, 
the dotted 45° lines of identity represent the situation 
where the intervention had not changed the behav-
ioural scores at all: a treatment effect would result in a 
consistent deviation away from this 45° line of identity. 
Significance for treatment effect was assessed using 
two-way ANOVA for matched samples (Table 1). There 
was, as expected, a significant treatment × time (pre- 
vs. post-treatment) interaction for the perceived pleas-
antness scale (Fig.  2a; Table  1). The median value did 
not change following rest (median 0, range −2 to +1 
units for post- minus pre-treatment values), whereas 
it increased by a median of 0.5 units (range −1 to +3 
units) following TM. A reverse pattern was seen for the 
heart rate (Fig. 2b): the heart rate dropped by a median 
of 8 beats/min (range of decrease 1–27 beats/min) fol-
lowing the rest period, whereas the corresponding drop 
for TM was smaller (3 beats/min, range of decrease 
−14 to 12 beats/min). Measures of anxiety and depres-
sion were also obtained for the participants, with the 
exception of one case pre-TM, and the behavioural 
scores are shown graphically in Fig. 2c–e. For the total 
state scores in the STAI-Y inventory, a significant main 
effect of time (i.e. pre vs. post-treatment) was seen, 
but no significant effects of either time × treatment or 
treatment per se. This can be seen as a downward shift 
relative to the dotted line in Fig.  2c. Corresponding 
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data for the Trait arm of the STAI-Y scale and the 
MADRS scale are shown Fig. 2d, e. Taken together, the 
main effect of TM over and above rest per se in this 
population was upon perceived pleasantness. 
Influence of the interventions upon blood levels of eCBs 
and related lipids
Plasma levels of 2-AG, AEA, the related NAEs 
PEA, SEA, POEA, OEA and LEA, and the related 
Fig. 1 Flow chart of the study showing the sampling times
Fig. 2 Effects of rest and TM upon a perceived pleasantness; b heart rate, c STAI‑state; d STAI‑trait and e MADRS scores of the subjects. The graphs 
show the individual data points, and the dotted lines are the 45° line of identity
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arachidonoyl derivative NA-Gly are shown in Fig.  3; 
the statistical treatment of the data are given in Table 1 
and the pre-: post-treatment correlation coefficients are 
given in Additional file  1. One sample was lost for the 
rest post-treatment group and one for the TM post-
treatment group. Thus, eighteen cases were evaluated on 
all four occasions. For only one compound did all four 
sample groups pass the D’Agostino and Pearson test for 
normality (NA-Gly), but this issue was rectified by use 
of logged values for 2-AG, PEA, SEA, OEA, LEA, POEA 
and square root values for AEA. Log10-transformed 
NA-Gly also passed the D’Agostino and Pearson test 
for normality. Two-way ANOVA for repeated measures 
conducted on the transformed data indicated no effect 
of time, treatment or the interaction time x treatment 
other than a significant effect of treatment (P =  0.029) 
for PEA, due to higher values for the rest occasions than 
on the TM occasions (Table  1). EPEA and DEA were 
also measured (Fig. 3h, i). These two compounds failed 
the D’Agostino and Pearson test for normality both for 
untransformed data and upon square root transforma-
tion. Log10 transformation was not undertaken due to 
the presence of zero (below the limit of detection) val-
ues. Two-way ANOVA for repeated measures on the 
rank-transformed values indicated that there were no 
effects of time, treatment or time × treatment on the 
levels of these two lipids (Table 1).
The availability of both biochemical and behavioural 
data allows analysis of associations to be made using 
non-parametric Spearman’s correlations. However, use 
of such a measure assumes that the relative reliability, 
defined by Baumgartner [25] as the “indication of the 
degree to which people maintain their position within 
a group” is acceptable. Here, the definition means the 
position of the lipid concentration for a given individual 
within the range seen for the whole sample.
We assessed the relative reliability of the lipids by com-
paring their pre-treatment values on the first visit (when 
they were blinded to the forthcoming treatment) and 
the second visit. The standard methods used to assess 
relative reliability are intraclass correlation coefficients 
(ICCs) and Lin’s concordance coefficient (Lin’s CCC), for 
which the sample sizes here are sufficient [25–28]. These 
tests are parametric, and so the transformed data were 
used (Table 2). Fleiss [28] suggested that ICC values <0.4, 
0.4–0.75 and  >0.75 can be taken to represent poor, fair 
to good, and excellent reliability, respectively. Using this 
measure, the data suggest that the measurements for 
LEA, OEA, POEA and NA-Gly have sufficient relative 
reliability for investigation of potential associations with 
the behavioural variables.
In Table  3, Spearman’s rho values for the correlation 
between the post- and pre-values for LEA, OEA, POEA 
and NA-Gly, and the corresponding changes for either 
the state scores or the heart rates, are presented. These 
were chosen since they are associated with anxiety and 
stress, and show the largest changes post- : pre-treatment 
of the variables investigated. None of the zero order cor-
relations reached significance. Table  2 also shows the 
correlations for “TM-selective” (sTM) change in lipid 
concentrations vs. the sTM for perceived pleasantness. 
The sTM values were calculated as the change over time 
for the TM group minus the change for the rest group, 
thereby reducing potential influences of time, food intake 
etc. [19, 29–33]. In this case, significant negative correla-
tions for LEA and POEA were found (Table 3).
Discussion
There is good evidence that TM produces a sense of well-
being in recipients and there are also studies suggesting 
that TM may also produce effects on blood pressure and 
heart rate as well as upon psychological emotions such 
as anxiety [24, 34–37]. An advantage of the cross-over 
design used here is that the individuals act as their own 
controls, and the first author of the present study has 
previously used this model, with a similar sample size 
(22 individuals) to demonstrate changes in heart rate 
and heart rate variability following TM [36]. In the pre-
sent study, an effect on the perceived pleasantness rat-
ing scale for TM was observed. This is consistent with 
Table 1 Statistical evaluation of  the datasets shown 
in Figs. 2 and 3
“Time” refers to pre- vs. post-treatment as main effect. Two-way paired ANOVA 
were conducted either on the ranked data [55] or upon the transformed values 
using the transformations shown in the Table
sqr square root
Measure N P value
Time Treatment Time × treatment
Perceived pleasantness 
(ranks)
20 0.018 0.018 0.0051
Heart rate (ranks) 19 <0.0001 0.25 0.019
STAI State (ranks) 19 <0.0001 0.31 0.61
STAI Trait (ranks) 19 0.0051 0.78 0.65
MADRS (ranks) 19 0.0019 0.88 0.95
2‑AG (log10) 18 0.37 0.30 0.67
AEA (sqr) 18 0.36 0.48 0.99
PEA (log10) 18 0.64 0.029 0.90
SEA (log10) 18 0.13 0.13 0.60
OEA (log10) 18 0.39 0.43 0.65
LEA (log10) 18 0.59 0.62 0.41
POEA (log10) 18 0.67 0.56 0.28
DEA (ranks) 18 0.36 0.74 0.080
EPEA (ranks) 18 0.24 0.27 0.40
NAGly (log10) 18 0.86 0.50 0.34
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Fig. 3 Effects of rest and TM upon the plasma levels of a 2‑AG; b AEA; c PEA; d SEA; e OEA; f LEA; g POEA; h EPEA; i DEA and j NA‑Gly (N = 18). The 
graphs show the individual data points, and the dotted lines are the 45° line of identity
Table 2 Relative reliability of measurements of endocannabinoids and six related lipids in human plasma samples
Median and IQR (interquartile ranges) are for the untransformed data in pM, and the P value comparing the two measurements are from Wilcoxon’s signed ranks 
matched pairs tests. The Lin’s CCC and ICC (1,1) values are for the transformed data (log10 except for AEA where square root was used), required so that the data passed 
the D’Agostino and Pearson test of normality. Values in brackets are the 95 % confidence limits
Lipid 1st measurement 2nd measurement P value Relative reliability (transformed data)
Median IQR Median IQR Lin’s CCC ICC
2‑AG 3245 2024 3300 2541 0.57 0.15 (−0.24 to 0.51) 0.17 (−0.27 to 0.56)
AEA 358 212 364 237 >0.99 0.23 (−0.22 to 0.59) 0.24 (−0.20 to 0.61)
PEA 2572 1595 2074 1565 0.28 0.27 (−0.15 to 0.61) 0.29 (−0.16 to 0.64)
SEA 834 356 789 236 0.37 0.31 (−0.13 to 0.65) 0.33 (−0.11 to 0.67)
OEA 1785 869 1433 1094 0.19 0.46 (0.086 to 0.72) 0.47 (0.06 to 0.75)
LEA 3207 3199 2028 3118 0.17 0.64 (0.32 to 0.83) 0.64 (0.30 to 0.84)
POEA 416 620 342 955 0.45 0.51 (0.12 to 0.77) 0.53 (0.13 to 0.78)
NA‑Gly 627 469 617 352 0.84 0.41 (−0.025 to 0.71) 0.43 (0.006 to 0.73)
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a previous study from the first author, who showed that 
the increased level of perceived pleasantness was associ-
ated with an increased blood flow in the pregenual ante-
rior cingulate cortex [24], a brain region that is activated 
by pleasurable stimuli [38]. In contrast, effects upon the 
state arm of the STAI-Y scale over and above that seen 
for rest was not seen following TM in the present study. 
The most likely explanation of the lack of effect on this 
measure is that a floor effect is occurring, given that the 
volunteers were not overly anxious. Certainly, the TM 
protocol used here produces a notable reduction in the 
state scores in patients scheduled for elective aortic sur-
gery [37].
With respect to the biochemical measurements, no 
significant TM-induced changes, which would be appar-
ent as an interaction time × treatment, were seen at the 
group level for plasma concentrations of 2-AG, AEA or 
related lipids following either TM or rest. To our knowl-
edge, the only previous study investigating the response 
to the eCB system to a hands-on technique is that of 
McPartland et  al. [39], who investigated osteopathic 
manipulative treatment in non-naïve individuals. They 
did not find any significant change at the 5  % level in 
post-treatment serum levels of AEA, 2-AG or OEA com-
pared to pre-treatment levels following either active or 
sham treatment. The association of the eCB system with 
stress and anxiety is complex, and a synthesis of animal 
experimental data has suggested that the activity of this 
system needs to be kept within a narrow window [40]. 
In humans, blockade of CB1 receptors by rimonabant 
is associated with an unacceptable incidence of depres-
sive disorders and mood alterations with depressive 
symptoms and anxiety [18]. Rimonabant given acutely 
does not affect basal anxiety levels, but increases anxi-
ety under aversive conditions (simulated public speak-
ing) [41]. Conversely, in animal studies, potentiation of 
the eCB system by compounds inhibiting eCB catabolism 
produce potentially beneficial effects in models of anxi-
ety using conditions of high, but not low, aversiveness 
[42–44]. These data may suggest that the eCB system is 
only engaged once a threshold of anxiety is reached. The 
type of stress may also be important. Thus, the stress 
produced by the Trier Social Stress Task (a series of 
short stressful events including a mock job interview) is 
sufficient to produce increases in blood levels of AEA, 
although this may reflect a general increase in NAE lev-
els, since PEA and OEA levels were increased, whereas 
2-AG and the related monoacylglycerol 2-oleoylglyc-
erol levels were not changed [15]. Levels of these NAEs 
were not changed during unstressed conditions [15]. In 
healthy males participating for the first time in repeat 
parabolic flights, individuals responding with motion 
sickness showed an increased stress score, and this was 
accompanied by a reduction in AEA compared to indi-
viduals who did not feel motion sickness after the 10th 
parabola [45]. These examples are of fairly strong stress-
ors, whereas the individuals in our studywere not unduly 
stressed or anxious. A lack of effect upon blood eCB 
levels is thus consistent with the “threshold of anxiety” 
hypothesis described above.
With respect to the related NAEs, the situation may be 
different: Schrieks et  al. [19] reported that in their ran-
domised cross-over study there were state-dependent 
changes in PEA and SEA levels in their study investigat-
ing the effects of ambience upon plasma levels of these 
lipids. These authors followed the levels of AEA, 2-AG, 
PEA, SEA, OEA and docohexanoylethanolamine (DHEA) 
in plasma at baseline, and 30 and 120 min following the 
partaking of a meal with or without alcohol and in either 
a pleasant or an unpleasant atmosphere, created by envi-
ronmental cues (lighting, cleanliness, choice of music 
etc.). The authors found a significant interaction effect of 
Table 3 Correlations between  plasma lipid, state, heart 
rate and perceived pleasantness scores
The Table shows Zero and first order Spearman’s rho values between the 
change in plasma levels of LEA, OEA, POEA and NA-Gly and the change in 
state scores and heart rates after either rest or TM and the TM-selective (sTM) 
change in perceived pleasantness (N = 18–19). The changes (shown as ∆) were 
calculated as (post-minus the corresponding pre-treatment value). sTM refers 
to calculations designed to minimise any effects of time and rest and were 
calculated as (post-TM minus pre-TM) − (post-rest minus pre-rest). The first order 
Spearman correlation coefficients controlling for the time elapse between the 
two measurement occasions (“Gap”) or for the BMI at the start of the study were 
calculated by the method of Lehmann [56]
* P ≤ 0.025, †  P < 0.05, otherwise not significant
Condition ∆State score ∆Heart rate sTM perceived  
pleasantness score




 Rest 0.13 −0.27
 TM 0.41 0.05
 sTM 0.05 0.05 0.03
∆LEA
 Rest −0.11 −0.26
 TM 0.37 −0.22
 sTM −0.54* −0.54* −0.55*
∆POEA
 Rest −0.03 −0.44
 TM 0.14 −0.28
 sTM −0.53* −0.53† −0.52†
∆NA‑Gly
 Rest 0.42 −0.10
 TM −0.01 −0.16
 sTM 0.12 0.12 0.08
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time × ambience, so that at the 30 min time point, both 
PEA and SEA levels (expressed as change from base-
line) were lower in the pleasant ambience arms of the 
study than in the unpleasant ambience arms (both with 
or without alcohol for SEA, with alcohol only for PEA) 
whereas the changes in 2-AG and AEA levels were not. 
It would certainly be worth designing future studies to 
investigate the effects of TM upon plasma eCB and NAE 
levels in individuals with higher stress/anxiety levels.
The present study has also investigated whether 
changes in the concentrations of LEA, OEA, POEA 
and NA-Gly were associated with changes in the state 
scores, the heart rates and the “TM-selective” change 
in perceived pleasantness. At first sight, the results sug-
gest that this may be so, a result in line with the study 
of Schrieks et al. [19], who found significant correlations 
with changes between baseline and 120  min of their 
lipid measurements and mood scores in their question-
naire for the pleasant ambiance without alcohol arm of 
study. Mood scores in that study were assessed using 
the Profile of Mood States questionnaire with additional 
questions from the Brunel mood scale. All in all, seven 
measures (anger, depression, fatigue, tension, vigour, 
happiness and calmness) were quantitated and signifi-
cant positive correlations were found between ∆AEA 
as well as ∆DHEA and ∆fatigue, and between ∆SEA 
and ∆calmness, whilst negative correlations were found 
between ∆2-AG, ∆PEA and ∆happiness, and for ∆OEA 
and ∆vigour [19]. However, it is wise to remember that 
the significant correlations from both the present study 
and that of Schrieks et  al. [19] result from multiple 
testing. In the case of [19] the total number of correla-
tion coefficients that can be obtained from the pleasant 
ambience without alcohol arm of the study is presum-
ably 42 (6 lipids, seven behavioural scores), and in our 
case there were 12 zero-order correlation coefficients. 
There is a trade-off between running the risk of report-
ing Type I errors (since some of the correlation coeffi-
cients would be expected to be significant on a purely 
random basis) and of reporting Type II errors when con-
servative corrections, such as the Bonferroni correction, 
are used. It can be argued that in exploratory studies of 
this type, the Bonferroni correction is too draconian (for 
[19] the presumed 42 comparisons for the arm in ques-
tion would, upon implementation of the Bonferroni 
correction, reduce the minimum level of significance to 
0.0012, which would leave but a single correlation as sig-
nificant; the same would be true for the less conservative 
false discovery rate method of Benjamini and Hochberg 
[46]). Thus, a reasonable conclusion to make is that the 
significant correlations found in that study and here are 
consistent with the hypothesis that the circulating levels 
of endocannabinoids and related NAEs are responsive to 
environmental cues, but confirmation of these explora-
tory findings is necessary.
Conclusions
It is concluded that in the participants studied here, there 
are no overt effects of TM upon plasma endocannabinoid 
levels. Possible associations of related N-acylethanola-




This study was approved by the Regional Ethical Review 
Board in Umeå (Dnr 2014-133-32 M) and the procedures 
were conducted in accordance with the Declaration of 
Helsinki. All subjects were informed of the purpose and 
risks of the experiment before the study and gave their 
written consent. The study was carried out from Septem-
ber 2014 to February 2015.
Subjects
Twenty healthy participants [10 men and 10 women, 
mean age = 25.2 years; standard deviation (SD) = 4.3 and 
mean body mass index = 23.8; SD = 3.1 at the start of the 
study] were recruited via posters. Nineteen of the partici-
pants were students and one participant worked at the 
University. Participants were excluded if they were smok-
ers, took medications, or had a history of drug abuse.
Design
The study had a randomized two-session crossover 
design with one condition that consisted of TM and 
a rest condition as control. A sequential number was 
assigned to an opaque envelope, which contained the 
assigned treatment group for the participant (half of the 
participants started with the rest condition and the other 
half started with the TM condition). The subjects partici-
pated twice with a minimum of 2 days and maximum of 
56 days apart (median value 14 days; the data was posi-
tively skewed). Participants were instructed to have the 
same breakfast on both occasions and not to take any caf-
feine in the morning when the study occurred.
Procedure
The study took place at the same settings and at the same 
time each day (see Fig.  1 for a flow chart). The partici-
pants were prepared with a venous catheter (PVC) at 8.30 
a.m. and rested in supine position for 10 min before the 
blood samples (“pre-measures”) were collected into BD 
Vacutainer® acrylic based polymer gel tubes contain-
ing spray dried lithium heparin. At the same time blood 
pressure and heart rate were measured. The participants 
completed questionnaires (see below) before the rest/TM 
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condition, starting at 9.15 a.m. During the “rest” session, 
the participants rested for 60  min. During the TM ses-
sion, the participants received TM on legs, back, head, 
arms and hands for 60  min. The body parts not being 
massaged were covered with a blanket. The same person 
that conducted the TM was also present in the room for 
the rest session.
At 10.20 a.m., blood samples were collected, and blood 
pressure and heart rate were measured, after which the 
participants again filled in the questionnaires. All blood 
samples were centrifuged (15 min at RT) within 10 min 
of collection, and the plasma was then kept on dry ice 
until storage at −80 °C. Thus, the pre-treatment samples 
were placed on dry ice at ~9:10 a.m., the post-treatment 
samples at ~10:40 a.m. and then delivered to the analysis 
unit at 11–11:30 a.m. where they were rapidly frozen at 
−80 °C. Under these conditions, degradation of eCBs has 
been reported to be minimal, although extended times at 
room temperature are not recommended [47].
Intervention
TM is a calm gentle massage with slow (0–5  cm/min) 
stroking movement at a pressure of about 2.5  N [24, 
37]. TM is similar to tactile massage, gentle or soft mas-
sage and includes effleurage. There are several different 
massage techniques, some involving the muscles, oth-
ers involving the skin. In Sweden, the term TM is used 
to cover different forms of light massage involving the 
skin. These forms of massage are characterized by gentle 
touches of the skin involving light pressure effleurage and 
long, calm stroking movements intended to increase the 
well-being [48], pleasure [49] and relaxation [35] of the 
recipients.
Subjective measures
To assess subjective effects upon perceived pleasant-
ness and behaviours associated with anxiety, stress and 
depression, several different instruments were used. Per-
ceived pleasantness was self assessed by the participants 
by rating how they experienced the moving touch stimu-
lation on a visual analogue scale ranging from −5 (very 
unpleasant), 0 neutral, and +5 (very pleasant). This scale 
has previously been used for evaluation of pleasant touch 
stimulation [24, 37].
The Swedish version of the STAI-Y instrument was 
used to assess self-reported anxiety levels pre and post 
intervention/control. The STAY-Y was designed to meas-
ure State-Anxiety as a temporary condition of anxiety 
and Trait-Anxiety as a more underlying condition. The 
instrument has good construct validity, internal con-
sistency, and test–retest validity [50, 51]. The 20 items 
are rated on a 4-point scale and after reversing positive 
items, the total score ranges from 20 to 80, with higher 
scores reflecting higher levels of anxiety. The STAI-Y 
instrument is sensitive enough to evaluate anxiety in 
small groups.
The participants subjective stress levels were rated on 
a visual analogue scale ranging from 0  =  no perceived 
stress to 5  =  very high perceived stress. MADRS was 
used for subjective experience of depression [52]. The 
MADRS consists of 9 items rated on a 7-point scale 
(0–6), which are summated to give a total score.
Heart rate was measured using an automatic blood 
pressure monitor, M6 Comfort, Omron Healthcare 
Europe, Netherlands.
Saliva cortisol
Salivary samples were collected by chewing a cylindrical 
cotton swab (Salivette, Sarstedt, Numbrecht, Germany). 
The samples were frozen at −20  °C until assayed. High 
performance liquid chromatography (HPLC) (Shimadzu 
Nexera) coupled to liquid chromatography tandem mass 
spectrometry (LC–MS/MS) (Sciex Qtrap 5500), was used 
for the analyses. The analyses were conducted in the 
Clinical Chemical Laboratory at the University Hospital, 
Umeå, Sweden.
Chemical and reagents for the lipid analyses
The following native and deuterated standards were pur-
chased from Cayman Chemicals (Ann Arbor, MI, USA): 
2-AG, AEA, PEA, SEA, OEA, LEA, POEA, EPEA, DEA, 
NA-Gly, 2-AG-d8, AEA-d8, PEA-d4, SEA-d3, OEA-d4, 
12-[[(cyclohexylamino)carbonyl]amino]-dodecanoic acid 
(CUDA). Acetonitrile and methanol were from Merck 
(Darmstadt, Germany). Isopropanol was from VWR 
PROLABO (Fontenay-sous-Bois, France). Acetic acid 
was purchased from Aldrich Chemical Company, Inc. 
(Milwaukee, WI, USA). Butylhydroxytoluene (BHT) was 
from Cayman Chemical (Ann Arbor, MI, USA) and eth-
ylenediaminetetraacetic acid (EDTA) from Fluka Ana-
lytical, Sigma-Aldrich (Buchs, Switzerland). Glycerol was 
from Fischer Scientific (Loughborough, UK). All solvents 
and chemicals were of HPLC grade or higher. Water was 
purified by a Milli-Q Gradient system (Millipore, Mil-
ford, MA, USA).
Preparation of native lipid standards and deuterated 
internal standard curves
Analytical quantification standards were used as ready-
made standard stock solutions or as solutions prepared 
from solid substances and stored at −80  °C. 2-AG was 
prepared and stored in acetonitrile and the other stand-
ards were prepared and stored in ethanol. Final stock 
solution concentrations of native standards were: 250 µg/
mL (2-AG, LEA and POEA), 125  µg/mL (AEA, PEA, 
OEA, DEA, EPEA, NA-Gly) and 83 µg/mL (SEA). Stock 
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solutions of deuterated internal standards were pre-
pared to a final concentration of 40 µg/mL (2-AG-d8) and 
10 µg/mL (AEA-d4, PEA-d4, SEA-d3, OEA-d4).
For each native compound, a suitable internal stand-
ard was selected based on structural similarities and 
added to samples before extraction. The internal stand-
ards were: 2-AG-d8, AEA-d4, SEA-d3, OEA-d4 (used for 
POEA, EPEA and NA-Gly as well as OEA) and PEA-d4 
(used for LEA and DEA as well as PEA). Recovery rates 
of each internal standard were calculated by normalisa-
tion against the recovery standard CUDA added in the 
last step before injection.
Sample preparation for lipid analysis
Sample preparation was undertaken according to our 
previously validated method [53]. Briefly, plasma samples 
(500 µL) were thawed on ice and spiked with 20 µL inter-
nal standard solution (800  ng/mL 2-AG-d8, and 20  ng/
mL AEA-d4, OEA-d4, SEA-d3 and PEA-d4) and 10 μL 
antioxidant solution [0.2  mg/mL BHT/EDTA in metha-
nol/water (1:1)] and then applied to pre-washed and con-
ditioned solid phase extraction SPE cartridges (Waters 
Oasis HLB cartridges; 60 mg of sorbent, 30 µm particle 
size). After loading the sample containing internal stand-
ard and antioxidant solution, the cartridges were washed, 
dried under high vacuum for about 1  min, and eluted 
with 3 mL acetonitrile, followed by 2 mL of methanol and 
1 mL of ethyl acetate into polypropylene tubes contain-
ing 6 μL of a glycerol solution (30 % in methanol). Eluates 
were concentrated with a MiniVac system (Farmingdale, 
NY, USA), reconstituted in 100 μL of methanol and vor-
texed (if necessary centrifuged to remove any residuals). 
Solutions were then transferred to LC vials with low-vol-
ume inserts, 10 μL of CUDA (50 ng/mL) was added, and 
LC–MS/MS analysis was performed immediately.
Instrumentation used for chromatographic separation 
and detection of lipids
Lipid analysis was performed using an Agilent UPLC sys-
tem (Infinity 1290) coupled with an electrospray ioniza-
tion source (ESI) to an Agilent 6490 Triple Quadrupole 
system equipped with the iFunnel Technology (Agilent 
Technologies, Santa Clara, CA, USA) operating in posi-
tive mode [54]. Analyte separation was performed using 
a Waters BEH C18 column (2.1 mm × 150 mm, 1.7 µm 
particle size) with 10 µL injection volume. The mobile 
phase consisted of (A) 0.1 % acetic acid in MilliQ water 
and (B) acetonitrile : isopropanol (90:10). The following 
gradient was employed: 0.0–2.0  min 30–45  % B, 2.0–
2.5  min 45–79  % B, 2.5–11.5  min 79  % B, 11.5–12  min 
79–90 % B, 12–14 min 90 % B, 14–14.5 min 90–79 % B, 
14.5–15.5 min 79 % B, 15.6–19 min 30 % B.
Precursor ions, [M+H]+ product ions, multiple reac-
tion monitoring (MRM) transitions and optimal collision 
energies were optimized for each analyte. ESI conditions 
were: capillary and nozzle voltage at 4000 and 1500  V, 
drying gas temperature 230  °C with a gas flow of 15 L/
min, sheath gas temperature 400 °C with a gas flow of 11 
L/min. The nebulizer gas flow was 35 psi, and iFunnel 
high and low pressure RF at 150 and 60 V. The dynamic 
MRM option was used for all compounds with optimized 
transitions and collision energies. The MassHunter 
Workstation software was used to control acquisition 
and manually integrate all peaks. The intra- and interday 
precision and accuracy measures of the lipids using this 
QqQ system are reported in detail elsewhere [54].
Statistics
Wilcoxon’s signed ranks tests, paired signed ranks tests, 
non-parametric bivariate correlations, D’Agostino and 
Pearson normality tests were undertaken using v. 6 for 
the Macintosh (GraphPad Software Inc., San Diego, 
CA, USA). Intraclass correlation coefficients and two-
way repeated- measures ANOVA were obtained using 
SPSS software v.22 for the Macintosh (IBM). Lin’s con-
cordance correlation coefficients were calculated online 
using the facility provided by the National Institute of 
Water and Atmospheric Research (https://www.niwa.
co.nz/node/104318/concordance; URL checked 17 
August 2015). The confidence limits for the differences 
between non-overlapping correlations (Additional file 1) 
were calculated using a Microsoft Spreadsheet provided 
by Dr. Thom Baguley at https://seriousstats.wordpress.
com/2012/02/05/comparing-correlations/, URL checked 
17 August 2015).
Availability of supporting data
The data sets supporting the results of this article are 
included within the article.
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